Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#ANDA070802 ×

Regulatory Updates

Sep 16, 2026•1 min read

FDA Discontinues HALOPERIDOL Injectable (ANDA070802)

The FDA has marked the HALOPERIDOL injectable (product 001) as discontinued under application ANDA070802 submitted by Smith & Nephew.